Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole gel for bacterial vaginosis in Malawi
NCT00140764Phase 3Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Jan 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of metronidazole in bacterial vaginosis (BV), sponsored by Johns Hopkins Bloomberg School of Public Health. Started Jan 2003; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT00140764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140764.